Nikao

Nikao has teamed up with DermaSensor to develop their ground-breaking technology that uses artificial intelligence to help users evaluate skin lesions for cancer. The device, undergoing clinical trials, would allow physicians and eventually consumers to perform simple skin checks in physician offices and patient homes at the first sign of a potential problem. Nikao will be the exclusive developer of the Proprietary Technology that utilizes light-emitting technology to evaluate potentially cancerous lesions on the surface of a patient’s skin.

DermaSensor was founded in 2009 by healthcare investor and serial entrepreneur Dr. Maurice Ferré, who was previously the CEO of MAKO Surgical, which sold to Stryker for $1.65 billion. Ferré, son of the former Miami mayor, is also chairman and CEO of Insightec, a brain health company founded in Israel; co-founder of Miami-based Fastrack Institute; and on the board of Endeavor Miami, an organization that supports high-impact entrepreneurship.